CARM
Price
$0.40
Change
+$0.08 (+25.00%)
Updated
Sep 5 closing price
Capitalization
16.79M
KZIA
Price
$7.95
Change
-$0.14 (-1.73%)
Updated
Sep 5, 04:22 PM (EDT)
Capitalization
8.67M
Interact to see
Advertisement

CARM vs KZIA

Header iconCARM vs KZIA Comparison
Open Charts CARM vs KZIABanner chart's image
Carisma Therapeutics
Price$0.40
Change+$0.08 (+25.00%)
Volume$7.12M
Capitalization16.79M
Kazia Therapeutics
Price$7.95
Change-$0.14 (-1.73%)
Volume$300
Capitalization8.67M
CARM vs KZIA Comparison Chart in %
Loading...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CARM vs. KZIA commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARM is a StrongBuy and KZIA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CARM: $0.40 vs. KZIA: $7.76)
Brand notoriety: CARM and KZIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CARM: 63% vs. KZIA: 2%
Market capitalization -- CARM: $16.79M vs. KZIA: $8.67M
CARM [@Biotechnology] is valued at $16.79M. KZIA’s [@Biotechnology] market capitalization is $8.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARM’s FA Score shows that 0 FA rating(s) are green whileKZIA’s FA Score has 0 green FA rating(s).

  • CARM’s FA Score: 0 green, 5 red.
  • KZIA’s FA Score: 0 green, 5 red.
According to our system of comparison, KZIA is a better buy in the long-term than CARM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARM’s TA Score shows that 5 TA indicator(s) are bullish while KZIA’s TA Score has 6 bullish TA indicator(s).

  • CARM’s TA Score: 5 bullish, 5 bearish.
  • KZIA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KZIA is a better buy in the short-term than CARM.

Price Growth

CARM (@Biotechnology) experienced а +86.93% price change this week, while KZIA (@Biotechnology) price change was -3.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CARM($16.8M) has a higher market cap than KZIA($8.68M). CARM YTD gains are higher at: -4.035 vs. KZIA (-8.588).
CARMKZIACARM / KZIA
Capitalization16.8M8.68M194%
EBITDA-44.04MN/A-
Gain YTD-4.035-8.58847%
P/E RatioN/AN/A-
Revenue10.8MN/A-
Total Cash2MN/A-
Total Debt1.7MN/A-
FUNDAMENTALS RATINGS
CARM vs KZIA: Fundamental Ratings
CARM
KZIA
OUTLOOK RATING
1..100
3053
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
5448
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KZIA's Valuation (43) in the Biotechnology industry is somewhat better than the same rating for CARM (92) in the null industry. This means that KZIA’s stock grew somewhat faster than CARM’s over the last 12 months.

KZIA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CARM (100) in the null industry. This means that KZIA’s stock grew similarly to CARM’s over the last 12 months.

KZIA's SMR Rating (99) in the Biotechnology industry is in the same range as CARM (100) in the null industry. This means that KZIA’s stock grew similarly to CARM’s over the last 12 months.

KZIA's Price Growth Rating (48) in the Biotechnology industry is in the same range as CARM (54) in the null industry. This means that KZIA’s stock grew similarly to CARM’s over the last 12 months.

KZIA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CARM (100) in the null industry. This means that KZIA’s stock grew similarly to CARM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CARMKZIA
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 24 days ago
83%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KYTX3.940.31
+8.54%
Kyverna Therapeutics
AAPG40.501.92
+4.97%
Ascentage Pharma Group
IR80.951.75
+2.21%
Ingersoll Rand
CTLP10.81-0.04
-0.37%
Cantaloupe
AIMD3.49-0.14
-3.86%
AINOS Inc

CARM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CARM has been loosely correlated with EVGN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CARM jumps, then EVGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARM
1D Price
Change %
CARM100%
+25.59%
EVGN - CARM
58%
Loosely correlated
+0.25%
INSM - CARM
45%
Loosely correlated
+1.80%
KZIA - CARM
35%
Loosely correlated
-4.08%
CYTK - CARM
33%
Loosely correlated
+6.55%
PMVP - CARM
33%
Loosely correlated
+1.39%
More

KZIA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZIA has been loosely correlated with CARM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if KZIA jumps, then CARM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
+0.75%
CARM - KZIA
35%
Loosely correlated
-13.49%
SGMO - KZIA
30%
Poorly correlated
-0.71%
LGVN - KZIA
30%
Poorly correlated
-8.31%
CING - KZIA
27%
Poorly correlated
+2.43%
TECX - KZIA
27%
Poorly correlated
+5.79%
More